VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2020 | Treating patients with RCC in 2020 and beyond

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, gives her thoughts on how the field of renal cell carcinoma (RCC) is evolving, in particular the development of a patient-based treatment strategy, including the use of a gene expression signature to determine treatment pathways in patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter